Semax — Research Overview

A synthetic heptapeptide derived from ACTH (4-10) developed in Russia with extensive research history. Studied for BDNF upregulation, cognitive enhancement, memory and focus improvement, neurological recovery, and stress resilience. One of the most well-characterized nootropic peptides in the preclinical literature.

Back to Peptide Encyclopedia